STE News

STERIS Announces Financial Results for Fiscal 2026 First Quarter

STE

DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 first quarter ended June 30, 2025. Total revenue from continuing operations for the first quarter of fiscal 2026 increased 9% to $1.4 billion compared with $1.3 billion in the first quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations for the first quarter was 8%.

August 6, 2025Earnings
Read more →

This Sun Communities Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

STE

May 29, 2025
Read more →

Jefferies Initiates Coverage On Steris with Hold Rating, Announces Price Target of $263

STE

May 29, 2025
Read more →

Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

STE

May 19, 2025
Read more →

Morgan Stanley Maintains Equal-Weight on Steris, Raises Price Target to $260

STE

May 19, 2025
Read more →

JMP Securities Maintains Market Outperform on Steris, Raises Price Target to $280

STE

May 16, 2025
Read more →

Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target

STE

May 15, 2025
Read more →

Steris Sees FY2026 expects reported revenue from continuing operations to increase 6-7%.

STE

May 14, 2025
Read more →

Steris Sees FY2026 GAAP EPS $7.82-$8.07 vs $7.87 Est

STE

May 14, 2025
Read more →

Steris Sees FY2026 Adj EPS $9.90-$10.15 vs $9.87 Est

STE

May 14, 2025
Read more →

Steris Q4 Adj. EPS $2.74 Beats $2.59 Estimate, Sales $1.48B Beat $1.47B Estimate

STE

May 14, 2025
Read more →

Beyond The Numbers: 4 Analysts Discuss Steris Stock

STE

April 10, 2025
Read more →

JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target

STE

April 10, 2025
Read more →

Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

STE

November 18, 2024
Read more →

JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target

STE

November 18, 2024
Read more →

Steris Reiterates FY25 As Reported Revenue To Increase 6.5-7.5%, Adj EPS From Continuing Operations To Be $9.05 - $9.25, Est $9.16

STE

November 6, 2024
Read more →

Steris Q2 2025 Sales $1.328B, Miss $1.33B Estimate

STE

November 6, 2024
Read more →

Steris Q2 2025 Adj EPS $2.14 Beats $2.12 Estimate

STE

November 6, 2024
Read more →